Euro-Med Laboratories Philippines (PHS:EURO) Total Liabilities: ₱4,957 Mil (As of Mar. 2026)


PHS:EURO Euro-Med Laboratories Philippines Inc PHS:EURO
83 GF Score
Price ₱1.06
GF Value ₱1.03
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Euro-Med Laboratories Philippines Total Liabilities?

Euro-Med Laboratories Philippines PHS:EURO -3.64% 83 Total Liabilities is ₱4,957 Mil as of Mar. 2026. GuruFocus rates PHS:EURO with a GF Score™ of 83/100 and a GF Value™ of ₱1.03 (Fairly Valued). The stock has 7 warning signs investors should review.

Euro-Med Laboratories Philippines's Total Liabilities for the quarter that ended in Mar. 2026 was ₱4,957 Mil.

Euro-Med Laboratories Philippines's quarterly Total Liabilities increased from Sep. 2025 (₱4,881.17 Mil) to Dec. 2025 (₱5,076.46 Mil) but then declined from Dec. 2025 (₱5,076.46 Mil) to Mar. 2026 (₱4,957.09 Mil).

Euro-Med Laboratories Philippines's annual Total Liabilities increased from Dec. 2023 (₱4,918.73 Mil) to Dec. 2024 (₱5,067.01 Mil) and increased from Dec. 2024 (₱5,067.01 Mil) to Dec. 2025 (₱5,076.46 Mil).

Euro-Med Laboratories Philippines Total Liabilities Historical Data

* Premium members only.

The historical data trend for Euro-Med Laboratories Philippines's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Euro-Med Laboratories Philippines Total Liabilities Chart

Euro-Med Laboratories Philippines Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4,050.73 4,349.83 4,918.73 5,067.01 5,076.46

Euro-Med Laboratories Philippines Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4,956.19 4,846.96 4,881.17 5,076.46 4,957.09
PHS:EURO
83GF Score
Euro-Med Laboratories Philippines Inc PHS:EURO
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Euro-Med Laboratories Philippines Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Euro-Med Laboratories Philippines's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=3832.621+(962.68+0.00100000000009
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+281.154+0)
=5,076

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=11144.61-6068.155
=5,076

Euro-Med Laboratories Philippines's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=3754.351+(920.52+-2.2737367544323E-13
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+282.222+0)
=4,957

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=11110.34-6153.247
=4,957

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of ₱4,957 Mil mean?
Euro-Med Laboratories Philippines (PHS:EURO) has a Total Liabilities of ₱4,957 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Euro-Med Laboratories Philippines and its competitors.
Is Euro-Med Laboratories Philippines' Total Liabilities too high?
Euro-Med Laboratories Philippines' current Total Liabilities is ₱4,957 Mil. Overall, Euro-Med Laboratories Philippines has a GF Score™ of 83/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Euro-Med Laboratories Philippines' Total Liabilities compare to ZTS and UTHR?
Euro-Med Laboratories Philippines' Total Liabilities of ₱4,957 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Drug Manufacturers company?
A good Total Liabilities depends on the Drug Manufacturers industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Euro-Med Laboratories Philippines and its competitors. Euro-Med Laboratories Philippines's current Total Liabilities is ₱4,957 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Euro-Med Laboratories Philippines stock overvalued right now?
Based on GuruFocus' analysis, Euro-Med Laboratories Philippines (PHS:EURO) is currently considered Fairly Valued. The stock's GF Value™ is ₱1.03, compared to a current price of ₱1.06 — trading 2.9% above its estimated fair value. The current Total Liabilities is ₱4,957 Mil. Euro-Med Laboratories Philippines' overall GF Score™ is 83/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Euro-Med Laboratories Philippines (PHS:EURO), the current Total Liabilities is ₱4,957 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Euro-Med Laboratories Philippines (PHS:EURO) Overvalued in 2026?

Based on GuruFocus' analysis, Euro-Med Laboratories Philippines stock appears to be overvalued. The current stock price of ₱1.06 is trading 2.9% above its estimated GF Value™ of ₱1.03. GuruFocus considers Euro-Med Laboratories Philippines to be Fairly Valued.

Key valuation signals for PHS:EURO:

  • Total Liabilities: ₱4,957 Mil
  • GF Value™: ₱1.03 vs. price of ₱1.06 (2.9% above fair value)
  • GF Score™: 83/100 with 7 warning signs

No single metric tells the full story. See the PHS:EURO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Euro-Med Laboratories Philippines Business Description

Address San Marcelino Street, United Nations Avenue corner, PPL Building, 2nd floor, Manila, PHL, 1000
Euro-Med Laboratories Philippines Inc is a pharmaceutical-based company that engages in the manufacture of pharmaceutical products such as large and small-volume parenterals and other solutions. The company also manufactures sterile water for injection, and other solutions such as ophthalmic, inhalation, irrigation, and dialysis. The Company also manufactures intravenous fluids in glass bottles, hemodialysis concentrates, ophthalmic products and disinfectants.
83GF Score

Get the complete analysis for PHS:EURO

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₱1.06
Price
₱1.03
GF Value